WallStreetZenWallStreetZen

NASDAQ: TENX
Tenax Therapeutics Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their TENX stock forecasts and price targets.

Forecast return on equity

Is TENX forecast to generate an efficient return?

Company
-2.35%
Industry
146.26%
Market
80.85%
TENX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TENX forecast to generate an efficient return on assets?

Company
-2.24%
Industry
36.38%
TENX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TENX earnings per share forecast

What is TENX's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$4.03
Avg 2 year Forecast
-$2.51
Avg 3 year Forecast
-$2.23

TENX revenue forecast

What is TENX's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$140.4M
Avg 2 year Forecast
$185.4M
Avg 3 year Forecast
$231.3M

TENX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TENX$5.67N/AN/A
NRSN$0.97N/AN/A
CVM$0.29N/AN/A
ASBP$0.47N/AN/A
PULM$6.30N/AN/A
View Top Biotech Stocks

Tenax Therapeutics Stock Forecast FAQ

What is TENX's earnings growth forecast for 2025-2027?

(NASDAQ: TENX) Tenax Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 12.73%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.6%.

Tenax Therapeutics's earnings in 2025 is -$17,602,000.On average, 3 Wall Street analysts forecast TENX's earnings for 2025 to be -$16,000,652, with the lowest TENX earnings forecast at -$41,530,227, and the highest TENX earnings forecast at -$3,017,493. On average, 3 Wall Street analysts forecast TENX's earnings for 2026 to be -$9,952,564, with the lowest TENX earnings forecast at -$22,869,418, and the highest TENX earnings forecast at -$3,255,716.

In 2027, TENX is forecast to generate -$8,840,856 in earnings, with the lowest earnings forecast at -$19,296,071 and the highest earnings forecast at -$3,136,604.

If you're new to stock investing, here's how to buy Tenax Therapeutics stock.

What is TENX's revenue growth forecast for 2027-2029?

(NASDAQ: TENX) Tenax Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 64.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.18%.

Tenax Therapeutics's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast TENX's revenue for 2027 to be $557,322,942, with the lowest TENX revenue forecast at $557,322,942, and the highest TENX revenue forecast at $557,322,942. On average, 1 Wall Street analysts forecast TENX's revenue for 2028 to be $736,069,675, with the lowest TENX revenue forecast at $736,069,675, and the highest TENX revenue forecast at $736,069,675.

In 2029, TENX is forecast to generate $918,171,383 in revenue, with the lowest revenue forecast at $539,575,322 and the highest revenue forecast at $1,296,767,445.

What is TENX's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: TENX) forecast ROA is -2.24%, which is lower than the forecast US Biotechnology industry average of 36.38%.

What is TENX's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: TENX) Tenax Therapeutics's current Earnings Per Share (EPS) is -$1.15. On average, analysts forecast that TENX's EPS will be -$4.03 for 2025, with the lowest EPS forecast at -$10.46, and the highest EPS forecast at -$0.76. On average, analysts forecast that TENX's EPS will be -$2.51 for 2026, with the lowest EPS forecast at -$5.76, and the highest EPS forecast at -$0.82. In 2027, TENX's EPS is forecast to hit -$2.23 (min: -$4.86, max: -$0.79).

What is TENX's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: TENX) forecast ROE is -2.35%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.